Literature DB >> 28207261

Cyclotheonellazoles A-C, Potent Protease Inhibitors from the Marine Sponge Theonella aff. swinhoei.

Michal Issac1, Maurice Aknin2, Anne Gauvin-Bialecki2, Nicole De Voogd3, Alisson Ledoux4, Michel Frederich4, Yoel Kashman1, Shmuel Carmeli1.   

Abstract

The extract of a sample of the sponge Theonella aff. swinhoei collected in Madagascar exhibited promising in vitro antiplasmodial activity. The antiplasmodial activity was ascribed in part to the known metabolite swinholide A. Further investigation of the extract afforded three unusual cyclic peptides, cyclotheonellazoles A-C (1-3), which contain six nonproteinogenic amino acids out of the eight acid units that compose these natural products. Among these acids the most novel were 4-propenoyl-2-tyrosylthiazole and 3-amino-4-methyl-2-oxohexanoic acid. The structure of the compounds was elucidated by interpretation of the 1D and 2D NMR data, HRESIMS, and advanced Merfay's techniques. The new compounds were found to be nanomolar inhibitors of chymotrypsin and sub-nanomolar inhibitors of elastase, but did not present antiplasmodial activity.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28207261     DOI: 10.1021/acs.jnatprod.7b00028

Source DB:  PubMed          Journal:  J Nat Prod        ISSN: 0163-3864            Impact factor:   4.050


  7 in total

Review 1.  Cyclic azole-homologated peptides from Marine sponges.

Authors:  Tadeusz F Molinski
Journal:  Org Biomol Chem       Date:  2017-12-19       Impact factor: 3.876

Review 2.  Natural Bioactive Thiazole-Based Peptides from Marine Resources: Structural and Pharmacological Aspects.

Authors:  Rajiv Dahiya; Sunita Dahiya; Neeraj Kumar Fuloria; Suresh Kumar; Rita Mourya; Suresh V Chennupati; Satish Jankie; Hemendra Gautam; Sunil Singh; Sanjay Kumar Karan; Sandeep Maharaj; Shivkanya Fuloria; Jyoti Shrivastava; Alka Agarwal; Shamjeet Singh; Awadh Kishor; Gunjan Jadon; Ajay Sharma
Journal:  Mar Drugs       Date:  2020-06-24       Impact factor: 5.118

Review 3.  Unraveling Plant Natural Chemical Diversity for Drug Discovery Purposes.

Authors:  Emmanuelle Lautié; Olivier Russo; Pierre Ducrot; Jean A Boutin
Journal:  Front Pharmacol       Date:  2020-04-07       Impact factor: 5.810

Review 4.  Marine Pharmacology in 2016-2017: Marine Compounds with Antibacterial, Antidiabetic, Antifungal, Anti-Inflammatory, Antiprotozoal, Antituberculosis and Antiviral Activities; Affecting the Immune and Nervous Systems, and Other Miscellaneous Mechanisms of Action.

Authors:  Alejandro M S Mayer; Aimee J Guerrero; Abimael D Rodríguez; Orazio Taglialatela-Scafati; Fumiaki Nakamura; Nobuhiro Fusetani
Journal:  Mar Drugs       Date:  2021-01-21       Impact factor: 5.118

5.  Elastase Inhibitor Cyclotheonellazole A: Total Synthesis and In Vivo Biological Evaluation for Acute Lung Injury.

Authors:  Yingjun Cui; Mengyi Zhang; Honglei Xu; Tingrong Zhang; Songming Zhang; Xiuhe Zhao; Peng Jiang; Jing Li; Baijun Ye; Yuanjun Sun; Mukuo Wang; Yangping Deng; Qing Meng; Yang Liu; Qiang Fu; Jianping Lin; Liang Wang; Yue Chen
Journal:  J Med Chem       Date:  2022-01-10       Impact factor: 7.446

6.  Native metabolomics identifies the rivulariapeptolide family of protease inhibitors.

Authors:  Raphael Reher; Allegra T Aron; Pavla Fajtová; Paolo Stincone; Berenike Wagner; Alicia I Pérez-Lorente; Chenxi Liu; Ido Y Ben Shalom; Wout Bittremieux; Mingxun Wang; Kyowon Jeong; Marie L Matos-Hernandez; Kelsey L Alexander; Eduardo J Caro-Diaz; C Benjamin Naman; J H William Scanlan; Phil M M Hochban; Wibke E Diederich; Carlos Molina-Santiago; Diego Romero; Khaled A Selim; Peter Sass; Heike Brötz-Oesterhelt; Chambers C Hughes; Pieter C Dorrestein; Anthony J O'Donoghue; William H Gerwick; Daniel Petras
Journal:  Nat Commun       Date:  2022-08-08       Impact factor: 17.694

Review 7.  Peptide Human Neutrophil Elastase Inhibitors from Natural Sources: An Overview.

Authors:  Lorenza Marinaccio; Azzurra Stefanucci; Giuseppe Scioli; Alice Della Valle; Gokhan Zengin; Angelo Cichelli; Adriano Mollica
Journal:  Int J Mol Sci       Date:  2022-03-08       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.